Array
(
[id] => 1331
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1331.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Improved surgical haemostatic devices and the use of topical haemostatic agents are suggested for reducing bleeding and blood products requirement during liver resections.（Evidence level: low；Recommendation grade: weak）
[laiyuan] => 建议改进手术止血装置和使用局部止血剂，以减少肝切除术期间出血和血液制品的需求。（证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议改进手术止血装置和使用局部止血剂，以减少肝切除术期间出血和血液制品的需求。（证据级别：低；推荐强度：弱推荐）
Improved surgical haemostatic devices and the use of topical haemostatic agents are suggested for reducing bleeding and blood products requirement during liver resections.（Evidence level: low；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1332
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1332.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Pre-operative continuation of aspirin monotherapy might be considered in liver resection patients. （Evidence level: low；Recommendation grade: weak）
[laiyuan] => 肝切除术患者术前可考虑继续阿司匹林单药治疗。证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
肝切除术患者术前可考虑继续阿司匹林单药治疗。证据级别：低；推荐强度：弱推荐）
Pre-operative continuation of aspirin monotherapy might be considered in liver resection patients. （Evidence level: low；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1333
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1333.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => VHA could be considered for the peri-operative detection of hypercoagulability and venous thromboembolic risk in CLD and in patients undergoing liver resection for cholangiocarcinoma. （Evidence level: low；Recommendation grade: weak）
[laiyuan] => N黏弹性止血试验可用于慢性肝病和胆管癌肝切除术患者围术期高凝性和静脉血栓栓塞风险的检测。证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
N黏弹性止血试验可用于慢性肝病和胆管癌肝切除术患者围术期高凝性和静脉血栓栓塞风险的检测。证据级别：低；推荐强度：弱推荐）
VHA could be considered for the peri-operative detection of hypercoagulability and venous thromboembolic risk in CLD and in patients undergoing liver resection for cholangiocarcinoma. （Evidence level: low；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1334
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1334.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => We suggest that TXA should be considered in cirrhotic patients undergoing liver resection. （Evidence level: low；Recommendation grade: weak）
[laiyuan] => 我们建议在肝硬化患者行肝切除术时应考虑到氨甲环酸。（证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们建议在肝硬化患者行肝切除术时应考虑到氨甲环酸。（证据级别：低；推荐强度：弱推荐）
We suggest that TXA should be considered in cirrhotic patients undergoing liver resection. （Evidence level: low；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1335
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1335.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => A strategy for lowering portal pressure during the dissection and liver resection phases (using a low CVP strategy by fluid restriction and/or phlebotomy, vasopressors) and VHA-guided transfusion protocols are recommended to decrease blood products transfusion rates during orthotopic liver transplantation (OLT). （Evidence level: low；Recommendation grade:strong）
[laiyuan] => 建议在解剖和肝切除阶段采用降低门静脉压力的策略(通过限制液体和/或静脉切开术、血管加压剂使用低中心静脉压策略)和黏弹性止血试验引导的输血方案，以降低原位肝移植(原位肝移植)期间的血液制品输注率。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
建议在解剖和肝切除阶段采用降低门静脉压力的策略(通过限制液体和/或静脉切开术、血管加压剂使用低中心静脉压策略)和黏弹性止血试验引导的输血方案，以降低原位肝移植(原位肝移植)期间的血液制品输注率。（证据级别：低；推荐强度：强推荐）
A strategy for lowering portal pressure during the dissection and liver resection phases (using a low CVP strategy by fluid restriction and/or phlebotomy, vasopressors) and VHA-guided transfusion protocols are recommended to decrease blood products transfusion rates during orthotopic liver transplantation (OLT). （Evidence level: low；Recommendation grade:strong）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1336
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1336.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Conventional coagulation tests with results outside the reference range in the absence of anticoagulant therapy do not reliably predict bleeding or exclude hypercoagulability in patients with CLD. （Evidence level: low）
[laiyuan] => 在没有抗凝治疗的情况下，常规凝血试验结果超出参考范围，不能可靠地预测慢性肝病患者的出血或排除高凝性。（证据级别：低）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在没有抗凝治疗的情况下，常规凝血试验结果超出参考范围，不能可靠地预测慢性肝病患者的出血或排除高凝性。（证据级别：低）
Conventional coagulation tests with results outside the reference range in the absence of anticoagulant therapy do not reliably predict bleeding or exclude hypercoagulability in patients with CLD. （Evidence level: low）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1337
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1337.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => Preoperative VHA may be useful in predicting blood loss and intra operative transfusion requirements in liver transplantation.（Evidence level: low）
[laiyuan] => 术前黏弹性止血试验可用于预测肝移植的出血量和术中输血需求。（证据级别：低）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
术前黏弹性止血试验可用于预测肝移植的出血量和术中输血需求。（证据级别：低）
Preoperative VHA may be useful in predicting blood loss and intra operative transfusion requirements in liver transplantation.（Evidence level: low）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1338
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1338.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In patients undergoing liver transplantation, VHA monitoring with assessment of fibrinogen is recommended for guiding fibrinogen replacement.（Evidence level: low；Recommendation grade:strong）
[laiyuan] => 在接受肝移植的患者中，建议监测黏弹性止血试验并评估纤维蛋白原，以指导纤维蛋白原的替代。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
在接受肝移植的患者中，建议监测黏弹性止血试验并评估纤维蛋白原，以指导纤维蛋白原的替代。（证据级别：低；推荐强度：强推荐）
In patients undergoing liver transplantation, VHA monitoring with assessment of fibrinogen is recommended for guiding fibrinogen replacement.（Evidence level: low；Recommendation grade:strong）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1339
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1339.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => In postoperative liver transplant patients, VHA with fibrinogen assessment may be considered for postoperative monitoring of coagulation together with VHAguided use of coagulation factors and/or blood products. （Evidence level: low；Recommendation grade: weak）
[laiyuan] => 肝移植术后可考虑采用VHA联合纤维蛋白原检测进行术后凝血功能监测，并指导凝血因子和(或)血液制品的使用。（证据级别：低；推荐强度：弱推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
肝移植术后可考虑采用VHA联合纤维蛋白原检测进行术后凝血功能监测，并指导凝血因子和(或)血液制品的使用。（证据级别：低；推荐强度：弱推荐）
In postoperative liver transplant patients, VHA with fibrinogen assessment may be considered for postoperative monitoring of coagulation together with VHAguided use of coagulation factors and/or blood products. （Evidence level: low；Recommendation grade: weak）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
Array
(
[id] => 1340
[catid] => 297
[title] => Management of severe peri-operative bleeding: Guidelines from the European Society of Anaesthesiology and Intensive Care
[thumb] =>
[keywords] =>
[description] =>
[hits] =>
[uid] => 1
[author] => 系统管理员
[status] => 9
[url] => https://www.anes-guide.com/show/1340.html
[link_id] => 0
[tableid] => 0
[inputip] => 14.105.95.222
[inputtime] => 2024-01-11 15:24:30
[updatetime] => 2024-01-11 15:24:30
[displayorder] => 0
[nrjc] => Array
(
)
[nrsh] => Array
(
)
[xzl] => 0
[dzl] => 0
[wailian] => https://pubmed.ncbi.nlm.nih.gov/36855941/
[demo_url] =>
[zjpjff] => GRADE
[zjfj] =>
[tjqd] =>
[nianfen] => 2023
[guojia] => the European Society of Anaesthesiology and Intens
[pdf] =>
[tjyjyw] =>
[lyyw] => We recommend TXA for treatment of fibrinolysis in OLT but not for routine prophylaxis; marginal grafts (donation after cardiac death) increase the risk of fibrinolysis postreperfusion.（Evidence level: low；Recommendation grade:strong）
[laiyuan] => 我们推荐TXA用于肝移植纤溶治疗，但不推荐用于常规预防;边缘移植物(心脏死亡后器官捐献)增加了再灌注后纤溶的风险。（证据级别：低；推荐强度：强推荐）
[znzldj] => B
[_inputtime] => 1704957870
[_updatetime] => 1704957870
[_nrjc] =>
[_nrsh] =>
)
推荐意见
我们推荐TXA用于肝移植纤溶治疗，但不推荐用于常规预防;边缘移植物(心脏死亡后器官捐献)增加了再灌注后纤溶的风险。（证据级别：低；推荐强度：强推荐）
We recommend TXA for treatment of fibrinolysis in OLT but not for routine prophylaxis; marginal grafts (donation after cardiac death) increase the risk of fibrinolysis postreperfusion.（Evidence level: low；Recommendation grade:strong）
证据评价方法：GRADE
指南质量等级：B
年份：2023
国家：the European Society of Anaesthesiology and Intens
